Meeder Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-33
| Closed | -$1K | – | 2169 |
|
|
2022
Q2 | $1K | Hold |
33
| – | – | ﹤0.01% | 1993 |
|
|
2022
Q1 | $1K | Hold |
33
| – | – | ﹤0.01% | 2154 |
|
|
2021
Q4 | $1K | Buy |
+33
| New | +$1K | ﹤0.01% | 1013 |
|
|
2018
Q3 | – | Sell |
-126
| Closed | -$954 | – | 1561 |
|
|
2018
Q2 | $954 | Buy |
126
+88
| +232% | +$666 | ﹤0.01% | 1504 |
|
|
2018
Q1 | $1K | Buy |
38
+14
| +58% | +$368 | ﹤0.01% | 1443 |
|
|
2017
Q4 | $1K | Buy |
+24
| New | +$1K | ﹤0.01% | 1556 |
|
|
2017
Q3 | – | Sell |
-63
| Closed | -$2K | – | 1641 |
|
|
2017
Q2 | $2K | Sell |
63
-56
| -47% | -$1.78K | ﹤0.01% | 1388 |
|
|
2017
Q1 | $6K | Sell |
119
-230
| -66% | -$11.6K | ﹤0.01% | 996 |
|
|
2016
Q4 | $19K | Buy |
+349
| New | +$19K | ﹤0.01% | 663 |
|